Top 20 Life Science Startups to Watch in 2019
BioSpace is proud to present its NextGen Bio “Class of 2019,” a list of 20 up-and-coming life science companies in North America that...
top of page
- Jan 4, 2019
Joining forces with Skyhawk, C4 Therapeutics, Biogen buys more shots on goal on SMA, Alzheimer’s
Amber Tong – Senior Editor These days at Biogen, the spotlight tends to fall on one of two programs: Its commercial SMA drug...
- Jan 4, 2019
Biogen looks to expand neuro pipeline via C4, Skyhawk deals
A pair of deals announced Friday leaves Biogen Inc. (NASDAQ:BIIB) poised to expand the druggable space of its neurology pipeline. Biogen...
- Jun 25, 2018
Skyhawk Announces Strategic Collaboration with Celgene to Discover and Develop Novel mRNA Splicing
Skyhawk Therapeutics Announces Strategic Collaboration with Celgene to Discover and Develop Novel mRNA Splicing Modifiers using Skyhawk’s...
- Jun 25, 2018
Biotech Celgene inks $60M deal with newcomer Skyhawk to develop RNA drugs for ALS, Huntington’s
by Conor Hale | Fierce Biotech Under the deal, Celgene received the exclusive option to license up to five drug candidates born out of...
- Jan 24, 2018
The new serial entrepreneur in the biotech arena launches another upstart looking to drug RNA
John Carroll – Editor & Founder After a lifetime of entrepreneurship, Bill Haney has discovered how much fun it can be to set up...
- Jan 24, 2018
Skyhawk, copying Dragonfly model, gets cash for RNA R&D
by Nick Paul Taylor Tim Disney—the great-nephew of Walt Disney—is among those who have signed term sheets. Skyhawk Therapeutics has...
- Jan 2, 2018
Disney, Family Offices Back Second Bio Startup from Tech Entrepreneur Haney
To launch his first biotech startup, Dragonfly Therapeutics, Bill Haney went to private family offices, including one linked to the...
Skyhawk News
bottom of page